Glucagon-like Peptide-1s, or GLP-1s, include high-profile brand names such as Ozempic, Wegovy, and Mounjaro
The specific thresholds that should prompt dose reduction or discontinuation include: ALT or AST elevation exceeding 3 times the patient's baseline value, new or worsening coagulopathy (INR increase of 0.5 or more from baseline), albumin decline below 2.5 g/dL, or new clinical signs of hepatic decompensation such as worsening ascites, encephalopathy, or jaundice [5]
Conversely, ferroptosis can feed back into the gut via metabolic products such as ROS through blood to aggravate gut dysbiosis, and then form a self-enhancing ferroptosis-gut dysfunction cycle in OA
In the first year, BCBS processed the claims of nearly 5 million Medicare patients
Unlike stimulants, theres no tolerance buildup or dependency
Data statistics are shown in Figure 5G